Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-536P (RNA, U6 small nuclear 536, pseudogene) is a human genomic locus classified as a **pseudogene** derived from the U6 small nuclear RNA (snRNA) family. Unlike its functional parent, U6 snRNA, which is a key component of the spliceosome involved in pre-mRNA splicing, RNU6-536P does not produce a functional RNA product or protein, and is annotated in genome databases as a noncoding pseudogene. Pseudogenes generally lack biological activity, but some pseudogenes in the genome may play regulatory roles by acting as microRNA decoys or influencing parental gene expression through RNA interference or epigenetic regulation. There is no published evidence for any such regulatory or disease-association function for RNU6-536P specifically. The functional U6 snRNA family is well-studied for its role in **spliceosomal catalysis**, but pseudogenes like RNU6-536P are often the result of genomic duplication events and do not contribute directly to cell biology or disease. Structural analysis has demonstrated that U6 pseudogenes have sequence similarity and may contain repetitive segments derived from their parental gene.
null
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 536, pseudogene (RNU6-536P).